Label-free Array Systems Market size is expected to grow at a CAGR of 7% during the forecast period and the market size is expected to reach nearly US$ 2.12 Bn. by 2029.Global Label-free Array Systems Market Dynamics
Label- free detection methods are extensively used to study molecular interactions over conventional label-based detection methods. Label- free detection has received significance in applications where detection using labels can compromise the target characteristic. For instance, fluorescent labels can also compromise protein function. Label-free methods permit actual-time dedication of dissociation and association rates of interacting molecules. Interferometry, surface plasmon resonance (SPR), diffraction, quartz crystal microbalance, and many others are unique techniques which can be used for label-free detection. Surface plasmon resonance (SPR) is the maximum generally used technique for label- free array systems.To know about the Research Methodology :- Request Free Sample Report The worldwide label-free array systems market growth is driven by using several factors like the developing range of drug discovery projects and growing choice for personalised or precision medicine. Furthermore, prominence with the aid of predominant players on the improvement of novel drug goals for the treatment of diverse chronic diseases, and rising investments in R&D help the growth of the label-free array systems marketplace. The label-free approach gets rid of using heavy fluorescent labels and other labels for the detection of latest molecules. This reduces the price of labelling, and thereby, the overall price of the test. However, the excessive cost of label- free array systems and alternate label-free technology such as mass spectrometers, microarrays, biochips may additionally obstruct the label-loose array systems market increase throughout the forecast period.
Global Label-free Array Systems Market Segment analysis
Based at the Technology, the surface plasmon resonance segment is projected to grow at a CAGR of xx% during the forecast period. The surface plasmon resonance (SPR) segment held the most important market share in 2022 and will also register quickest growth in the coming years. Surface plasmon resonance can be used as a substitute to dual or single color labeling detection techniques and therefore is an extensively used technique. SPR is a substantially-used technology in drug discovery, kinetic analysis, and antigen-antibody reaction in protein microarray. The big percentage of this technique is credited to easy obtainability and deep penetration. Based on application, the label- free array systems market is classified into antibody characterization and development, drug discovery, protein complex and cascade analysis, protein interface evaluation and other packages. The drug discovery application segment ruled the market in 2022 because of rising R&D activities and investments for new drug improvement activities. Fast growth is anticipated for antibody characterization and development segment above the estimated period owing to the developing demand for monoclonal antibody.Regional analysis
North America is anticipated to dominate the worldwide label-free array systems market throughout the estimate period. North America region accounted for a demand share of xx% in 2022 and is expected to reach as much as xx% by the end of 2029. This large share is credited to rising funds for new target identification and drug discovery by main biotechnology and pharmaceutical businesses and developing demand for modified medicinal drug. Europe becomes the second important regional market. Growing attention on new therapy development, availability of funds, an emerging number of drug discovery projects, rising demand for monoclonal antibodies are essential factors that help the marketplace increase in this region.Global Label-free Array Systems Market Recent Development
In November 2021, Agilent Technologies, Inc. acquired ACEA Biosciences, Inc. (ACEA), a developer of cell analysis tools, for nearly US$ 250 Mn. in cash, which aided it to expand its label-free array systems portfolio. The objective of the report is to present a comprehensive analysis of the Global Label-free Array Systems Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Label-free Array Systems Market dynamics, structure by analysing the market segments and projects the Global Label-free Array Systems Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.Global Label-free Array Systems Market Scope: Inquire before buying
Global Label-free Array Systems Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.32 Bn. Forecast Period 2023 to 2029 CAGR: 7% Market Size in 2029: US $ 2.12 Bn. Segments Covered: by Technology Surface Plasmon Resonance Bio Layer Interferometry Cellular Dielectric Spectroscopy Other Technologies by Application Protein Complex and Cascade Analysis Antibody Characterization and Development Protein Interface Analysis Drug Discovery Other Applications by End User Contract Research Organizations Biotechnology and Pharmaceutical Companies Academic and Research Institutes Other End Users By Regions
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Label-free Array Systems Market, Key Players
1. GE Healthcare 2. Attana AB 3. Agilent Technologies, Inc. 4. Danaher Corporation 5. F. Hoffmann-La Roche AG 6. Bio-Rad Laboratories 7. GWC Technologies 8. PerkinElmer, Inc. 9. BiOptix, Inc. 10.Corning Incorporated 11.Thermo Fisher Scientific 12.Attana AB 13.Molecular Devices, LLC 14.ForteBio 15.Eppendorf AG Frequently Asked Questions: 1. Which region has the largest share in Global Label-free Array Systems Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Label-free Array Systems Market? Ans: The Global market is growing at a CAGR of 7% during forecasting period 2023-2029. 3. What is scope of the Global Label-free Array Systems market report? Ans: Global Label-free Array Systems Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Label-free Array Systems market? Ans: The important key players in the Global Label-free Array Systems Market are – GE Healthcare, Attana AB, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, GWC Technologies, PerkinElmer, Inc., BiOptix, Inc., Corning Incorporated, Thermo Fisher Scientific, Attana AB, Molecular Devices, LLC, ForteBio, and Eppendorf AG 5. What is the study period of this market? Ans: The Global Label-free Array Systems Market is studied from 2022 to 2029.
Global Label-free Array Systems Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Label-free Array Systems Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Label-free Array Systems Market Analysis and Forecast 6.1. Global Label-free Array Systems Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Label-free Array Systems Market Analysis and Forecast, By Technology 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Label-free Array Systems Market Value Share Analysis, By Technology 7.4. Global Label-free Array Systems Market Size (US$ Bn) Forecast, By Technology 7.5. Global Label-free Array Systems Market Analysis, By Technology 7.6. Global Label-free Array Systems Market Attractiveness Analysis, By Technology 8. Global Label-free Array Systems Market Analysis and Forecast, By End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Label-free Array Systems Market Value Share Analysis, By End User 8.4. Global Label-free Array Systems Market Size (US$ Bn) Forecast, By End User 8.5. Global Label-free Array Systems Market Analysis, By End User 8.6. Global Label-free Array Systems Market Attractiveness Analysis, By End User 9. Global Label-free Array Systems Market Analysis and Forecast, By Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Label-free Array Systems Market Value Share Analysis, By Application 9.4. Global Label-free Array Systems Market Size (US$ Bn) Forecast, By Application 9.5. Global Label-free Array Systems Market Analysis, By Application 9.6. Global Label-free Array Systems Market Attractiveness Analysis, By Application 10. Global Label-free Array Systems Market Analysis, by Region 10.1. Global Label-free Array Systems Market Value Share Analysis, by Region 10.2. Global Label-free Array Systems Market Size (US$ Bn) Forecast, by Region 10.3. Global Label-free Array Systems Market Attractiveness Analysis, by Region 11. North America Label-free Array Systems Market Analysis 11.1. Key Findings 11.2. North America Label-free Array Systems Market Overview 11.3. North America Label-free Array Systems Market Value Share Analysis, By Technology 11.4. North America Label-free Array Systems Market Forecast, By Technology 11.4.1. Surface Plasmon Resonance 11.4.2. Bio Layer Interferometry 11.4.3. Cellular Dielectric Spectroscopy 11.4.4. Other Technologies 11.5. North America Label-free Array Systems Market Value Share Analysis, By End User 11.6. North America Label-free Array Systems Market Forecast, By End User 11.6.1. Contract Research Organizations 11.6.2. Biotechnology and Pharmaceutical Companies 11.6.3. Academic and Research Institutes 11.6.4. Other End Users 11.7. North America Label-free Array Systems Market Value Share Analysis, By Application 11.8. North America Label-free Array Systems Market Forecast, By Application 11.8.1. Protein Complex and Cascade Analysis 11.8.2. Antibody Characterization and Development 11.8.3. Protein Interface Analysis 11.8.4. Drug Discovery 11.8.5. Other Applications 11.9. North America Label-free Array Systems Market Value Share Analysis, by Country 11.10. North America Label-free Array Systems Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Label-free Array Systems Market Analysis, by Country 11.12. U.S. Label-free Array Systems Market Forecast, By Technology 11.12.1. Surface Plasmon Resonance 11.12.2. Bio Layer Interferometry 11.12.3. Cellular Dielectric Spectroscopy 11.12.4. Other Technologies 11.13. U.S. Label-free Array Systems Market Forecast, By End User 11.13.1. Contract Research Organizations 11.13.2. Biotechnology and Pharmaceutical Companies 11.13.3. Academic and Research Institutes 11.13.4. Other End Users 11.14. U.S. Label-free Array Systems Market Forecast, By Application 11.14.1. Protein Complex and Cascade Analysis 11.14.2. Antibody Characterization and Development 11.14.3. Protein Interface Analysis 11.14.4. Drug Discovery 11.14.5. Other Applications 11.15. Canada Label-free Array Systems Market Forecast, By Technology 11.15.1. Surface Plasmon Resonance 11.15.2. Bio Layer Interferometry 11.15.3. Cellular Dielectric Spectroscopy 11.15.4. Other Technologies 11.16. Canada Label-free Array Systems Market Forecast, By End User 11.16.1. Contract Research Organizations 11.16.2. Biotechnology and Pharmaceutical Companies 11.16.3. Academic and Research Institutes 11.16.4. Other End Users 11.17. Canada Label-free Array Systems Market Forecast, By Application 11.17.1. Protein Complex and Cascade Analysis 11.17.2. Antibody Characterization and Development 11.17.3. Protein Interface Analysis 11.17.4. Drug Discovery 11.17.5. Other Applications 11.18. North America Label-free Array Systems Market Attractiveness Analysis 11.18.1. By Technology 11.18.2. By End User 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Label-free Array Systems Market Analysis 12.1. Key Findings 12.2. Europe Label-free Array Systems Market Overview 12.3. Europe Label-free Array Systems Market Value Share Analysis, By Technology 12.4. Europe Label-free Array Systems Market Forecast, By Technology 12.4.1. Surface Plasmon Resonance 12.4.2. Bio Layer Interferometry 12.4.3. Cellular Dielectric Spectroscopy 12.4.4. Other Technologies 12.5. Europe Label-free Array Systems Market Value Share Analysis, By End User 12.6. Europe Label-free Array Systems Market Forecast, By End User 12.6.1. Contract Research Organizations 12.6.2. Biotechnology and Pharmaceutical Companies 12.6.3. Academic and Research Institutes 12.6.4. Other End Users 12.7. Europe Label-free Array Systems Market Value Share Analysis, By Application 12.8. Europe Label-free Array Systems Market Forecast, By Application 12.8.1. Protein Complex and Cascade Analysis 12.8.2. Antibody Characterization and Development 12.8.3. Protein Interface Analysis 12.8.4. Drug Discovery 12.8.5. Other Applications 12.9. Europe Label-free Array Systems Market Value Share Analysis, by Country 12.10. Europe Label-free Array Systems Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Label-free Array Systems Market Analysis, by Country 12.12. Germany Label-free Array Systems Market Forecast, By Technology 12.12.1. Surface Plasmon Resonance 12.12.2. Bio Layer Interferometry 12.12.3. Cellular Dielectric Spectroscopy 12.12.4. Other Technologies 12.13. Germany Label-free Array Systems Market Forecast, By End User 12.13.1. Contract Research Organizations 12.13.2. Biotechnology and Pharmaceutical Companies 12.13.3. Academic and Research Institutes 12.13.4. Other End Users 12.14. Germany Label-free Array Systems Market Forecast, By Application 12.14.1. Protein Complex and Cascade Analysis 12.14.2. Antibody Characterization and Development 12.14.3. Protein Interface Analysis 12.14.4. Drug Discovery 12.14.5. Other Applications 12.15. U.K. Label-free Array Systems Market Forecast, By Technology 12.15.1. Surface Plasmon Resonance 12.15.2. Bio Layer Interferometry 12.15.3. Cellular Dielectric Spectroscopy 12.15.4. Other Technologies 12.16. U.K. Label-free Array Systems Market Forecast, By End User 12.16.1. Contract Research Organizations 12.16.2. Biotechnology and Pharmaceutical Companies 12.16.3. Academic and Research Institutes 12.16.4. Other End Users 12.17. U.K. Label-free Array Systems Market Forecast, By Application 12.17.1. Protein Complex and Cascade Analysis 12.17.2. Antibody Characterization and Development 12.17.3. Protein Interface Analysis 12.17.4. Drug Discovery 12.17.5. Other Applications 12.18. France Label-free Array Systems Market Forecast, By Technology 12.18.1. Surface Plasmon Resonance 12.18.2. Bio Layer Interferometry 12.18.3. Cellular Dielectric Spectroscopy 12.18.4. Other Technologies 12.19. France Label-free Array Systems Market Forecast, By End User 12.19.1. Contract Research Organizations 12.19.2. Biotechnology and Pharmaceutical Companies 12.19.3. Academic and Research Institutes 12.19.4. Other End Users 12.20. France Label-free Array Systems Market Forecast, By Application 12.20.1. Protein Complex and Cascade Analysis 12.20.2. Antibody Characterization and Development 12.20.3. Protein Interface Analysis 12.20.4. Drug Discovery 12.20.5. Other Applications 12.21. Italy Label-free Array Systems Market Forecast, By Technology 12.21.1. Surface Plasmon Resonance 12.21.2. Bio Layer Interferometry 12.21.3. Cellular Dielectric Spectroscopy 12.21.4. Other Technologies 12.22. Italy Label-free Array Systems Market Forecast, By End User 12.22.1. Contract Research Organizations 12.22.2. Biotechnology and Pharmaceutical Companies 12.22.3. Academic and Research Institutes 12.22.4. Other End Users 12.23. Italy Label-free Array Systems Market Forecast, By Application 12.23.1. Protein Complex and Cascade Analysis 12.23.2. Antibody Characterization and Development 12.23.3. Protein Interface Analysis 12.23.4. Drug Discovery 12.23.5. Other Applications 12.24. Spain Label-free Array Systems Market Forecast, By Technology 12.24.1. Surface Plasmon Resonance 12.24.2. Bio Layer Interferometry 12.24.3. Cellular Dielectric Spectroscopy 12.24.4. Other Technologies 12.25. Spain Label-free Array Systems Market Forecast, By End User 12.25.1. Contract Research Organizations 12.25.2. Biotechnology and Pharmaceutical Companies 12.25.3. Academic and Research Institutes 12.25.4. Other End Users 12.26. Spain Label-free Array Systems Market Forecast, By Application 12.26.1. Protein Complex and Cascade Analysis 12.26.2. Antibody Characterization and Development 12.26.3. Protein Interface Analysis 12.26.4. Drug Discovery 12.26.5. Other Applications 12.27. Rest of Europe Label-free Array Systems Market Forecast, By Technology 12.27.1. Surface Plasmon Resonance 12.27.2. Bio Layer Interferometry 12.27.3. Cellular Dielectric Spectroscopy 12.27.4. Other Technologies 12.28. Rest of Europe Label-free Array Systems Market Forecast, By End User 12.28.1. Contract Research Organizations 12.28.2. Biotechnology and Pharmaceutical Companies 12.28.3. Academic and Research Institutes 12.28.4. Other End Users 12.29. Rest Of Europe Label-free Array Systems Market Forecast, By Application 12.29.1. Protein Complex and Cascade Analysis 12.29.2. Antibody Characterization and Development 12.29.3. Protein Interface Analysis 12.29.4. Drug Discovery 12.29.5. Other Applications 12.30. Europe Label-free Array Systems Market Attractiveness Analysis 12.30.1. By Technology 12.30.2. By End User 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Label-free Array Systems Market Analysis 13.1. Key Findings 13.2. Asia Pacific Label-free Array Systems Market Overview 13.3. Asia Pacific Label-free Array Systems Market Value Share Analysis, By Technology 13.4. Asia Pacific Label-free Array Systems Market Forecast, By Technology 13.4.1. Surface Plasmon Resonance 13.4.2. Bio Layer Interferometry 13.4.3. Cellular Dielectric Spectroscopy 13.4.4. Other Technologies 13.5. Asia Pacific Label-free Array Systems Market Value Share Analysis, By End User 13.6. Asia Pacific Label-free Array Systems Market Forecast, By End User 13.6.1. Contract Research Organizations 13.6.2. Biotechnology and Pharmaceutical Companies 13.6.3. Academic and Research Institutes 13.6.4. Other End Users 13.7. Asia Pacific Label-free Array Systems Market Value Share Analysis, By Application 13.8. Asia Pacific Label-free Array Systems Market Forecast, By Application 13.8.1. Protein Complex and Cascade Analysis 13.8.2. Antibody Characterization and Development 13.8.3. Protein Interface Analysis 13.8.4. Drug Discovery 13.8.5. Other Applications 13.9. Asia Pacific Label-free Array Systems Market Value Share Analysis, by Country 13.10. Asia Pacific Label-free Array Systems Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Label-free Array Systems Market Analysis, by Country 13.12. China Label-free Array Systems Market Forecast, By Technology 13.12.1. Surface Plasmon Resonance 13.12.2. Bio Layer Interferometry 13.12.3. Cellular Dielectric Spectroscopy 13.12.4. Other Technologies 13.13. China Label-free Array Systems Market Forecast, By End User 13.13.1. Contract Research Organizations 13.13.2. Biotechnology and Pharmaceutical Companies 13.13.3. Academic and Research Institutes 13.13.4. Other End Users 13.14. China Label-free Array Systems Market Forecast, By Application 13.14.1. Protein Complex and Cascade Analysis 13.14.2. Antibody Characterization and Development 13.14.3. Protein Interface Analysis 13.14.4. Drug Discovery 13.14.5. Other Applications 13.15. India Label-free Array Systems Market Forecast, By Technology 13.15.1. Surface Plasmon Resonance 13.15.2. Bio Layer Interferometry 13.15.3. Cellular Dielectric Spectroscopy 13.15.4. Other Technologies 13.16. India Label-free Array Systems Market Forecast, By End User 13.16.1. Contract Research Organizations 13.16.2. Biotechnology and Pharmaceutical Companies 13.16.3. Academic and Research Institutes 13.16.4. Other End Users 13.17. India Label-free Array Systems Market Forecast, By Application 13.17.1. Protein Complex and Cascade Analysis 13.17.2. Antibody Characterization and Development 13.17.3. Protein Interface Analysis 13.17.4. Drug Discovery 13.17.5. Other Applications 13.18. Japan Label-free Array Systems Market Forecast, By Technology 13.18.1. Surface Plasmon Resonance 13.18.2. Bio Layer Interferometry 13.18.3. Cellular Dielectric Spectroscopy 13.18.4. Other Technologies 13.19. Japan Label-free Array Systems Market Forecast, By End User 13.19.1. Contract Research Organizations 13.19.2. Biotechnology and Pharmaceutical Companies 13.19.3. Academic and Research Institutes 13.19.4. Other End Users 13.20. Japan Label-free Array Systems Market Forecast, By Application 13.20.1. Protein Complex and Cascade Analysis 13.20.2. Antibody Characterization and Development 13.20.3. Protein Interface Analysis 13.20.4. Drug Discovery 13.20.5. Other Applications 13.21. ASEAN Label-free Array Systems Market Forecast, By Technology 13.21.1. Surface Plasmon Resonance 13.21.2. Bio Layer Interferometry 13.21.3. Cellular Dielectric Spectroscopy 13.21.4. Other Technologies 13.22. ASEAN Label-free Array Systems Market Forecast, By End User 13.22.1. Contract Research Organizations 13.22.2. Biotechnology and Pharmaceutical Companies 13.22.3. Academic and Research Institutes 13.22.4. Other End Users 13.23. ASEAN Label-free Array Systems Market Forecast, By Application 13.23.1. Protein Complex and Cascade Analysis 13.23.2. Antibody Characterization and Development 13.23.3. Protein Interface Analysis 13.23.4. Drug Discovery 13.23.5. Other Applications 13.24. Rest of Asia Pacific Label-free Array Systems Market Forecast, By Technology 13.24.1. Surface Plasmon Resonance 13.24.2. Bio Layer Interferometry 13.24.3. Cellular Dielectric Spectroscopy 13.24.4. Other Technologies 13.25. Rest of Asia Pacific Label-free Array Systems Market Forecast, By End User 13.25.1. Contract Research Organizations 13.25.2. Biotechnology and Pharmaceutical Companies 13.25.3. Academic and Research Institutes 13.25.4. Other End Users 13.26. Rest of Asia Pacific Label-free Array Systems Market Forecast, By Application 13.26.1. Protein Complex and Cascade Analysis 13.26.2. Antibody Characterization and Development 13.26.3. Protein Interface Analysis 13.26.4. Drug Discovery 13.26.5. Other Applications 13.27. Asia Pacific Label-free Array Systems Market Attractiveness Analysis 13.27.1. By Technology 13.27.2. By End User 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Label-free Array Systems Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Label-free Array Systems Market Overview 14.3. Middle East & Africa Label-free Array Systems Market Value Share Analysis, By Technology 14.4. Middle East & Africa Label-free Array Systems Market Forecast, By Technology 14.4.1. Surface Plasmon Resonance 14.4.2. Bio Layer Interferometry 14.4.3. Cellular Dielectric Spectroscopy 14.4.4. Other Technologies 14.5. Middle East & Africa Label-free Array Systems Market Value Share Analysis, By End User 14.6. Middle East & Africa Label-free Array Systems Market Forecast, By End User 14.6.1. Contract Research Organizations 14.6.2. Biotechnology and Pharmaceutical Companies 14.6.3. Academic and Research Institutes 14.6.4. Other End Users 14.7. Middle East & Africa Label-free Array Systems Market Value Share Analysis, By Application 14.8. Middle East & Africa Label-free Array Systems Market Forecast, By Application 14.8.1. Protein Complex and Cascade Analysis 14.8.2. Antibody Characterization and Development 14.8.3. Protein Interface Analysis 14.8.4. Drug Discovery 14.8.5. Other Applications 14.9. Middle East & Africa Label-free Array Systems Market Value Share Analysis, by Country 14.10. Middle East & Africa Label-free Array Systems Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Label-free Array Systems Market Analysis, by Country 14.12. GCC Label-free Array Systems Market Forecast, By Technology 14.12.1. Surface Plasmon Resonance 14.12.2. Bio Layer Interferometry 14.12.3. Cellular Dielectric Spectroscopy 14.12.4. Other Technologies 14.13. GCC Label-free Array Systems Market Forecast, By End User 14.13.1. Contract Research Organizations 14.13.2. Biotechnology and Pharmaceutical Companies 14.13.3. Academic and Research Institutes 14.13.4. Other End Users 14.14. GCC Label-free Array Systems Market Forecast, By Application 14.14.1. Protein Complex and Cascade Analysis 14.14.2. Antibody Characterization and Development 14.14.3. Protein Interface Analysis 14.14.4. Drug Discovery 14.14.5. Other Applications 14.15. South Africa Label-free Array Systems Market Forecast, By Technology 14.15.1. Surface Plasmon Resonance 14.15.2. Bio Layer Interferometry 14.15.3. Cellular Dielectric Spectroscopy 14.15.4. Other Technologies 14.16. South Africa Label-free Array Systems Market Forecast, By End User 14.16.1. Contract Research Organizations 14.16.2. Biotechnology and Pharmaceutical Companies 14.16.3. Academic and Research Institutes 14.16.4. Other End Users 14.17. South Africa Label-free Array Systems Market Forecast, By Application 14.17.1. Protein Complex and Cascade Analysis 14.17.2. Antibody Characterization and Development 14.17.3. Protein Interface Analysis 14.17.4. Drug Discovery 14.17.5. Other Applications 14.18. Rest of Middle East & Africa Label-free Array Systems Market Forecast, By Technology 14.18.1. Surface Plasmon Resonance 14.18.2. Bio Layer Interferometry 14.18.3. Cellular Dielectric Spectroscopy 14.18.4. Other Technologies 14.19. Rest of Middle East & Africa Label-free Array Systems Market Forecast, By End User 14.19.1. Contract Research Organizations 14.19.2. Biotechnology and Pharmaceutical Companies 14.19.3. Academic and Research Institutes 14.19.4. Other End Users 14.20. Rest of Middle East & Africa Label-free Array Systems Market Forecast, By Application 14.20.1. Protein Complex and Cascade Analysis 14.20.2. Antibody Characterization and Development 14.20.3. Protein Interface Analysis 14.20.4. Drug Discovery 14.20.5. Other Applications 14.21. Middle East & Africa Label-free Array Systems Market Attractiveness Analysis 14.21.1. By Technology 14.21.2. By End User 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Label-free Array Systems Market Analysis 15.1. Key Findings 15.2. South America Label-free Array Systems Market Overview 15.3. South America Label-free Array Systems Market Value Share Analysis, By Technology 15.4. South America Label-free Array Systems Market Forecast, By Technology 15.4.1. Surface Plasmon Resonance 15.4.2. Bio Layer Interferometry 15.4.3. Cellular Dielectric Spectroscopy 15.4.4. Other Technologies 15.5. South America Label-free Array Systems Market Value Share Analysis, By End User 15.6. South America Label-free Array Systems Market Forecast, By End User 15.6.1. Contract Research Organizations 15.6.2. Biotechnology and Pharmaceutical Companies 15.6.3. Academic and Research Institutes 15.6.4. Other End Users 15.7. South America Label-free Array Systems Market Value Share Analysis, By Application 15.8. South America Label-free Array Systems Market Forecast, By Application 15.8.1. Protein Complex and Cascade Analysis 15.8.2. Antibody Characterization and Development 15.8.3. Protein Interface Analysis 15.8.4. Drug Discovery 15.8.5. Other Applications 15.9. South America Label-free Array Systems Market Value Share Analysis, by Country 15.10. South America Label-free Array Systems Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Label-free Array Systems Market Analysis, by Country 15.12. Brazil Label-free Array Systems Market Forecast, By Technology 15.12.1. Surface Plasmon Resonance 15.12.2. Bio Layer Interferometry 15.12.3. Cellular Dielectric Spectroscopy 15.12.4. Other Technologies 15.13. Brazil Label-free Array Systems Market Forecast, By End User 15.13.1. Contract Research Organizations 15.13.2. Biotechnology and Pharmaceutical Companies 15.13.3. Academic and Research Institutes 15.13.4. Other End Users 15.14. Brazil Label-free Array Systems Market Forecast, By Application 15.14.1. Protein Complex and Cascade Analysis 15.14.2. Antibody Characterization and Development 15.14.3. Protein Interface Analysis 15.14.4. Drug Discovery 15.14.5. Other Applications 15.15. Mexico Label-free Array Systems Market Forecast, By Technology 15.15.1. Surface Plasmon Resonance 15.15.2. Bio Layer Interferometry 15.15.3. Cellular Dielectric Spectroscopy 15.15.4. Other Technologies 15.16. Mexico Label-free Array Systems Market Forecast, By End User 15.16.1. Contract Research Organizations 15.16.2. Biotechnology and Pharmaceutical Companies 15.16.3. Academic and Research Institutes 15.16.4. Other End Users 15.17. Mexico Label-free Array Systems Market Forecast, By Application 15.17.1. Protein Complex and Cascade Analysis 15.17.2. Antibody Characterization and Development 15.17.3. Protein Interface Analysis 15.17.4. Drug Discovery 15.17.5. Other Applications 15.18. Rest of South America Label-free Array Systems Market Forecast, By Technology 15.18.1. Surface Plasmon Resonance 15.18.2. Bio Layer Interferometry 15.18.3. Cellular Dielectric Spectroscopy 15.18.4. Other Technologies 15.19. Rest of South America Label-free Array Systems Market Forecast, By End User 15.19.1. Contract Research Organizations 15.19.2. Biotechnology and Pharmaceutical Companies 15.19.3. Academic and Research Institutes 15.19.4. Other End Users 15.20. Rest of South America Label-free Array Systems Market Forecast, By Application 15.20.1. Protein Complex and Cascade Analysis 15.20.2. Antibody Characterization and Development 15.20.3. Protein Interface Analysis 15.20.4. Drug Discovery 15.20.5. Other Applications 15.21. South America Label-free Array Systems Market Attractiveness Analysis 15.21.1. By Technology 15.21.2. By End User 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. GE Healthcare 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Attana AB 16.3.3. Agilent Technologies, Inc. 16.3.4. Danaher Corporation 16.3.5. F. Hoffmann-La Roche AG 16.3.6. Bio-Rad Laboratories 16.3.7. GWC Technologies 16.3.8. PerkinElmer, Inc. 16.3.9. BiOptix, Inc. 16.3.10. Corning Incorporated 16.3.11. Thermo Fisher Scientific 16.3.12. Attana AB 16.3.13. Molecular Devices, LLC 16.3.14. ForteBio 16.3.15. Eppendorf AG 16.4. Primary Key Insights